Discover 677 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 677
Active & Responsive
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
for
Anger Problems, Aggression
Location: Fort Cavazos TX
Sponsor: The University of Texas Health Science Center at San Antonio
Sex: All
Age: 18+
Code: NCT06609330
Recruiting
Active & Responsive
Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children
for
PTSD, Depression, Parent-Child Relations
Location: Killeen TX, San Antonio TX, El Paso TX
Sponsor: New York University
Sex: Female
Age: 18+
Code: NCT06262178
Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Temple TX, Houston TX, Tulsa OK, Little Rock AR,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Temple TX, Georgetown TX, Mansfield TX, San Antonio TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
SELUTION 4 De Novo Small Vessel IDE Trial
for
Coronary Artery Disease
Location: Temple TX, Fort Worth TX, Dallas TX, Plano TX,
Sponsor: M.A. Med Alliance S.A.
Sex: All
Age: 18+
Code: NCT05946629
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
for
Obesity, Type 2 Diabetes
Location: Lampasas TX, Austin TX, San Antonio TX, Kerrville TX,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07564414
Phase3, Recruiting
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine